Literature DB >> 27926714

Pfizer drops phase 3 lipid-lowering antibody.

.   

Abstract

Entities:  

Year:  2016        PMID： 27926714     DOI： 10.1038/nbt1216-1214

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  New class PCSK9 blockers stride into cholesterol market.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2015-08       Impact factor: 54.908
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.